Navegando por Assunto "Sintomas depressivos"

Agora exibindo 1 - 2 de 2

Acesso aberto (Open Access)
Parkinson pai d’égua: protocolo de danças amazônicas sobre os parâmetros não motores e motores em pessoas com Parkinson
(Universidade Federal do Pará, 2024-06-25) COSTA, Carla Luana Alves; HAAS, Aline Nogueira; http://lattes.cnpq.br/6600425096998622; https://orcid.org/0000-0003-4583-0668; MONTEIRO, Elren Passos; http://lattes.cnpq.br/0920248966438368; https://orcid.org/0000-0001-7757-6620
Introduction: In Parkinson's disease, dopaminergic neurons degenerate. Dance has been shown to be a non-pharmacological intervention for PD symptoms. However, the benefits are mostly assessed in motor symptoms. However, it is believed that the characteristics of Amazonian dances can be a stimulus for improving and/or maintaining the motor and non motor symptoms of PD. However, no studies with Amazonian dances in people with Parkinson's were found Methods: The aim of the study was to analyze the responses of Amazonian dances and cultural manifestations on the non-motor symptoms of global cognition, mood, depressive symptoms and quality of life in people with Parkinson's in the Amazon region and to evaluate an intra-group control period of Health Education and compare it with the effects of dances. This is a longitudinal study. Participants will be people with Parkinson's of both sexes, stage 1 to 4 on the Hoehn and Yahr scale. The volunteers took part in evaluations before and after the Health Education period, Protocol and follow up. The data was collected and tabulated in Excel, and analyzed using SPSS software version 27.0. We used descriptive statistics to characterize the sample, and Generalized Estimating Equations to compare moments, groups and subtypes of PD. In addition, the effect size was calculated using Edges' d. Results When analyzing depressive symptoms, significant differences were found for the Group factor (p=0.049) and the ES intervention (7.00±1.15; 6.50±0.96). When we analyzed mood states by domains, for the Anger domain, the Group (p= 0.35) and Time (p= 0.66) factors did not show significant values. For global cognitive function, significant differences were found for the Group factor (p<0.001).Conclusion: The present study shows benefits of the Health Education Program of the Amazonian Dances and Cultural Manifestations protocol for PcP in non-motor symptoms of depressive symptoms in both interventions. This indicates that Amazonian dances and cultural manifestations can be used with caution for the rehabilitation of non-motor and motor symptoms in people with Parkinson's disease.
Acesso aberto (Open Access)
Vitamina D, qualidade de vida e alto risco de depressão em indivíduos com Diabetes Mellitus Tipo 2 e Doença Renal Diabética: um estudo transversal
(Universidade Federal do Pará, 2024-02-23) REIS, Melissa de Sá Oliveira dos; FELÍCIO, João Soares; http://lattes.cnpq.br/8482132737976863
Clinical Depression is highly prevalent in patients living with Diabetic Kidney Disease (DKD) and Diabetes Mellitus 2 (DM2) and is related to high morbidity and mortality, in addition, Health-Related Quality of Life (HRQoL) is also potentially impacted in these patients. Vitamin D (VD) deficiency has been associated with depression and worse HRQoL in patients with DRD. This study aims to investigate the association between vitamin D levels, HRQOL and depression in patients with DRD who are not receiving dialysis treatment. To this end, this was a cross-sectional study, which included 51 patients with DM2 and DRD, not on dialysis and with severely elevated albuminuria, treated at the João de Barros Barreto University Hospital. To measure depressive symptoms (SD), the Beck Depression Inventory (BDI) was used and HRQoL was analyzed using the EQ-5D-5L instrument. Additionally, the Glomerular Filtration Rate estimate was calculated by CKD-EPI Refit. Result: The prevalence of depression was 46.9% and was strongly associated with quality of life levels assessed by the EQ-5D. Impacting both domains and utility indices (Domain “Pain and discomfort” 0.7±0.8 vs 1.1±0.8, p<0.05; Utility index “United States” 0.89 [0.78-1] vs 0.71[0.60-0.84], p<0.05). Worse quality of life was even associated with the severity of depression. With regard to DV, it directly impacted HRQoL, but no direct association was found between DV and depression. Models with simple logistic regression showed that patients with peripheral neuropathy (PN) had a six times greater risk of experiencing depression (OR 6.56, R²=0.12, p<0.05). Additionally, the duration of DM2 was also important, with each year of illness increasing the risk of depression by 12% (OR 1.135, R²=0.18, p<0.05). The data suggested that depression has a high prevalence in patients with T2DM and DRD and is strongly associated with low levels of HRQoL. HV impacted quality of life, but was not directly associated with the prevalence and severity of depression.